Background/Aim. Intravenous drug users (IDUs) are still a high risk-group for cross-
negative results were found in 15 patients. All investigated IDUs were negative for HIV (ELISA/CIA and PCR testing) and for pathogens of opportunistic infection (Cryptococcus neoformans; Pneumocystis carini; PCR testing), as well as for West Nile Virus (PCR testing). Just one IDU was positive for syphilis (ELISA and confirmatory testing).
Conclusion. This investigation undoubtedly confirmed the effectiveness and improved safety of originally designed complementary (ELISA/CIA and PCR) pathogen monitoring system. Our study demonstrated that the positivity for HBV and HCV is still very high (33.4% and 84.8%, respectively) in IDUs. Thus, we suggest that drug users have to be periodically screened using a complementary serological/molecular testing -concerning differences/discrepancies in results obtained using these methods. The intravenous drug users (IDUs) face stigma not only due to psychological and behavioral aspects of their functioning, but also because of significantly higher rates of bloodborne and/or sexually transmitted infections due to unsafe injecting practices and risky sexual Chain Reaction (PCR) assays 7, 8 . 3 . It is necessary to determine the infectivity of the tested addicts and in terms of delineation of the test results: they did not come into contact with these viruses, the start of the infection -the "window" period, an infection, a past active infection.
The study aim was to evaluate the profile of opiate addict and above all the prevalence of blood-borne infections such as HBV, HCV and HIV among IDUs on substitution therapy with methadone and buprenorphine in Shumadia District of Serbia. The results of complementary ELISA or CIA and PCR testing were also compared in attempt to improve of pathogen monitoring system, as well as the diagnostic algorithm for this vulnerable population.
Methods

Patients/Subjects
In this study patients on substitution therapy with methadone or buprenorphine at 
Pathogen investigation methods
Total of 99 IDUs were tested using complementary serological and molecular testing.
All samples were taken into 9 ml tubes with K2EDTA (Bio-One Vacuette, Greiner), than the tubes were centrifuged at 3500 rpm, 30 minutes and plasma samples were analyzed.
Samples were initially tested by ELISA or CIA systems (Evolis, Biorad; Architect i2000 SR, Abbott) and afterward with s201 system (COBAS Ampliprep/ COBAS Taqman, Roche). Preliminary positive specimens were analyzed using ID (Individual Donation)
PCR. Preliminary negative samples were tested by mini-pool (MP) PCR technique (6 samples).
HCV ELISA/CIA-negative / PCR-positive samples were tested using confirmatory test (n=11; Innolia Innogenetics) 7 . In addition, all 99 IDUs were tested on pathogens of opportunistic infections, such as Cryptococcus neoformans and Pneumocystis carini. 
Statistical analysis
The data was presented as absolute numbers, median and percentages. The tables were used to present the socio-demographic characteristics of IDUs, as well as complementary serological and molecular investigations. The 2×2 contingency table was used to compare the results of serological and molecular testing. The statistical analyses were performed using SPSS 20.0 software. Differences were considered as statistically significant if the p value was less than 0.05.
Results
The majority of IDUs were male, city residents and dominantly with a completed secondary school -their characteristics are presented in Table 1 . Table 2 . Table 2 Absolute numbers of patients -analyzed by comparative serological and molecular testing for HCV vs. HBV in this study -are summarized in Table 3 and in Figure 1 . Table 3 and Figure 1 .
As presented, the number of HCV vs. HBV positive IDUs was significantly (p < 0.01) higher in our study group, using both ELISA or CIA and PCR techniques.
Regarding the opportunistic infections, all 99 IDUs were negative (PCR testing) for the most common pathogens: Cryptococcus neoformans, Pneumocystis carini and West Nile
Virus. Only one patient was positive on syphilis by ELISA, VDRL and TPHA. These results are presented in Table 4 . Table 4 The presented negativity for opportunistic infection pathogens can be explain because of no severe compromised immune system -since all IDUs were negative on HIV. In our study there is no HIV infection among IDUs and that is similar as prevalence in Iran (0.7%) and among blood donors tested earlier in MMA (0.005%) 8, 12 . Prevalence of HBV (33.3%) was lower than in the Italy (where the prevalence is 60.7%), while in Mexico is 85%, similar as in Greece and Portugal, but significant higher than prevalence in Uruguay (20%), Iran (0.7%) and among blood donors (0.20%) [13] [14] [15] . IDUs had a much higher probability of acquiring infection than non-injectors, confirming the role of intravenous transmission. The prevalence was highest for HCV infection (58.6%) and that is lower than prevalence observed in Estonia and Latvia (about 90%), Romania and Portugal, and similar as in Russia (73%). The HCV prevalence is higher than in Hungary (23%) and among blood donors (0.12%) [12] [13] [14] [15] [16] . 
Discussion
Conclusion
The majority of IDUs were male (aged 19-57 yrs), city residents and dominantly with a completed secondary school. This study undoubtedly demonstrated improved safety of originally designed complementary (ELISA/CIA and PCR) pathogen monitoring system. Our results confirmed that injecting drug practice continues to be an important risk factor for bloodborne infections; the positivity for HBV and HCV was still very high -33.4% and 84.8%, respectively. Thus, drug users have to be periodically screened by complementary serological/molecular testing -concerning differences/discrepancies in results obtained using these methods. Finally, we speculate that HBV vaccination should be actively obtainable/offered to all HBV-negative IDUs. Table 1 The socio-demographic characteristics of IDUs
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